Cori Jones
Gerontology · Gloucester, VANPI 1902458334
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $401 of the $583 with a category attached, or 68.7%. 9 manufacturers reported payments, led by Mallinckrodt Hospital Products Inc. at 42.9% of the total. Reporting peaked in 2024 at $180 and has fallen 75.4% since, to $44 in 2025.
Across 30 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$250
- Ardelyx, Inc.$110
- Calliditas Therapeutics US Inc.$48
- Fresenius USA Marketing, Inc.$42
- Travere Therapeutics, Inc.$41
- Akebia Therapeutics Inc$38
- plus $53 from 3 others
What the payments were for
- Food & beverage$40169%
- Education$18231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 9 | $250 |
| Ardelyx, Inc. | 5 | $110 |
| Calliditas Therapeutics US Inc. | 2 | $48 |
| Fresenius USA Marketing, Inc. | 3 | $42 |
| Travere Therapeutics, Inc. | 6 | $41 |
| Akebia Therapeutics Inc | 2 | $38 |
| Baxter Healthcare | 1 | $20 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Olympus America Inc. | 1 | $14 |
How this compares
$583 in reported general payments places this provider in the 60th percentile of 130 gerontology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 21 | $15,989 |
| Potassium Chloride | 31 | $11,078 |
| Tacrolimus | 11 | $3,781 |
| Clonidine | 22 | $3,717 |
| Calcitriol | 128 | $1,577 |
| Losartan Potassium | 118 | $1,116 |
| Allopurinol | 160 | $1,045 |
| Hydralazine Hcl | 100 | $781 |
| Amlodipine Besylate | 162 | $774 |
| Torsemide | 62 | $571 |
| Metoprolol Succinate | 43 | $534 |
| Furosemide | 54 | $393 |
| Minoxidil | 18 | $335 |
| Spironolactone | 55 | $332 |
| Carvedilol | 90 | $310 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Gloucester
- Lauren FerrisRoanoke$11K
- Catherine RatliffCharlottesville$10K
- Jennifer TaylorAbingdon$9K
- Alexander KingCharlottesville$7K
- Margaret HeidenreichChantilly$6K
- Jillian MaurielloRichmond$6K
- Christine HowellNorfolk$6K
- Molly McCrackenRichmond$5K
- Meredith OverstreetManassas$5K
- Danielle JenningsRichmond$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.